Evidence map›Paper›PMID 29033132›Full record

ArticleCell2017

Assembly and Function of Heterotypic Ubiquitin Chains in Cell-Cycle and Protein Quality Control.

Richard G Yau, Kerstin Doerner, Erick R Castellanos, Diane L Haakonsen, Achim Werner, Nan Wang, X William Yang, Nadia Martinez-Martin, Marissa L Matsumoto, Vishva M Dixit and 1 more

Open access · greenAbstract read
In one paragraph

Article in Cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 190 papers.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 326 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Function and regulation of the mitochondrial stress response.Nature structural & molecular biology · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. The Ubiquitin-Proteasome System in Brain Disorders: Pathogenic Pathways, Post-Translational Tweaks, and Therapeutic Frontiers.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
  18. Article
  19. Review
  20. Article

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Richard G YauDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, USA; Howard Hughes Medical Institute, Berkeley, CA, USA.
Kerstin DoernerDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, USA.
Erick R CastellanosDepartment of Structural Biology, Genentech Inc., South San Francisco, CA, USA.
Diane L HaakonsenDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, USA; Howard Hughes Medical Institute, Berkeley, CA, USA.
Achim WernerDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, USA.
Nan WangCenter for Neurobehavioral Genetics, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.
X William YangCenter for Neurobehavioral Genetics, Semel Institute for Neuroscience & Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.
Nadia Martinez-MartinDepartment of Microchemistry, Proteomics, and Lipidomics, Genentech Inc., South San Francisco, CA, USA.
Marissa L MatsumotoDepartment of Structural Biology, Genentech Inc., South San Francisco, CA, USA. Electronic address: matsumoto.marissa@gene.com.
Vishva M DixitDepartment of Physiological Chemistry, Genentech Inc., South San Francisco, CA, USA. Electronic address: dixit.vishva@gene.com.
Michael RapeDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, USA; Howard Hughes Medical Institute, Berkeley, CA, USA. Electronic address: mrape@berkeley.edu.
Howard Hughes Medical Institute · USUniversity of California, Berkeley · USUniversity of California, Los Angeles · US

Funding

Dissecting Mechanisms of Ubiquitination and Deubiquitination in Cell Cycle ControR01GM083064 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI RAPE, MICHAEL P · 2008 to 2016
$2.2M
Ubiquitin-dependent regulation of ribosome function in cell fate determinationK99DE025314 · NIDCR · UNIVERSITY OF CALIFORNIA BERKELEY · PI WERNER, ACHIM · 2015 to 2016
$245k
Howard Hughes Medical InstituteNIDCR NIH HHS K99 DE025314NIGMS NIH HHS R01 GM083064
6 · The paper itself

Abstract

Posttranslational modification with ubiquitin chains controls cell fate in all eukaryotes. Depending on the connectivity between subunits, different ubiquitin chain types trigger distinct outputs, as seen with K48- and K63-linked conjugates that drive protein degradation or complex assembly, respectively. Recent biochemical analyses also suggested roles for mixed or branched ubiquitin chains, yet without a method to monitor endogenous conjugates, the physiological significance of heterotypic polymers remained poorly understood. Here, we engineered a bispecific antibody to detect K11/K48-linked chains and identified mitotic regulators, misfolded nascent polypeptides, and pathological Huntingtin variants as their endogenous substrates. We show that K11/K48-linked chains are synthesized and processed by essential ubiquitin ligases and effectors that are mutated across neurodegenerative diseases; accordingly, these conjugates promote rapid proteasomal clearance of aggregation-prone proteins. By revealing key roles of K11/K48-linked chains in cell-cycle and quality control, we establish heterotypic ubiquitin conjugates as important carriers of biological information.

Indexed as

Signal TransductionAnaphase-Promoting Complex-CyclosomeAntibodies, BispecificCell CycleHumansMitosisProtein BiosynthesisUbiquitinUbiquitinationAnaphase-Promoting Complex-CyclosomeAntibodies, BispecificUbiquitinanaphase-promoting complexbranched ubiquitin chainHuntingtinHuntington’s diseaseproteasomeprotein quality controlubiquitinubiquitin chain

Identifiers

PMID29033132
PMCPMC5669814
OpenAlexW2762198049

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.